代表性成果
主持科技部国家重点研发计划、国家自然科学基金、卫计委重大专项课题、省市各级科研项目等。主持开展多项呼吸介入领域的前瞻性多中心临床研究和前沿基础研究。
1、Lisi Luo#, Junfeng Huang#, Difei Chen#, Huijie Yang#, Yuling Deng, Yushan He, Jinsheng Lin, Ruiyue Zhao, Xinlu Wang, Zhuquan Su, Huanjie Chen, Minting Wu, Yingying Gu, Zhucheng Chen, Ning Ma*, Shiyue Li*. Airway basal stem cell-derived extracellular vesicles drive ECM remodeling and suppress fibroblasts activation via the miR-30a-5p/FAP axis in benign tracheal stenosis.J Adv Res. 2026 May:83:759-773. doi: 10.1016/j.jare.2025.08.014. IF=17.1
2、Di-Fei Chen#, Zhu-Quan Su#, Yu-Long Luo#, Zi-Qing Zhou, Zu-Yuan Guo, Li-Hong Yao, Jing-Wei Liu, Yu Chen, Kian Fan Chung, Chang-Hao Zhong, Xiao-Bo Chen, Chun-Li Tang, Shi-Yue Li*. Establishment of a novel severe asthma canine model: Feasible research platform of respiratory intervention therapies. Allergy. 2025 May;80(5):1513-1517. doi: 10.1111/all.16207. IF=12
3、Junfeng Huang#, Difei Chen, Zikai Lin, Huijie Yang, Shiyue Li*.Sowing Tailored Seeds: Gene-edited Basal Cells for Precision Regulation of Airway Phenotypes.Am J Respir Crit Care Med.2025 Feb 25;211(5):883-884. doi: 10.1164/rccm.202412-2401LE. IF=19.4
4、Ming Liu #, Guihuan Qiu #, Wenhui Guan #, Xiaohong Xie, Xinqing Lin, Zhanhong Xie, Jiexia Zhang, Yinyin Qin, Haijian Du, Xin Chen, Yu Deng, Shiyue Li*, Nanshan Zhong*, Chengzhi Zhou*.Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial.Signal Transduct Target Ther. 2025 Feb 18;10(1):65.PMID: 39962074 IF=52.7
5、Junfeng Huang #, Zikai Lin #, Jinsheng Lin #, Shuojia Xie #, Shixin Xia, Gengjia Chen, Ziwen Zheng, Zhe Xu, Fangcheng Liu, Hongkai Wu*, Shiyue Li*. Causal role of lipid metabolism in pulmonary alveolar proteinosis: an observational and mendelian randomisation study. Thorax. 2024 Jan 18;79(2):135-143. doi: 10.1136/thorax-2023-220789. PMID: 38124156. IF=10